Leber hereditary optic neuropathy (LHON) is an inherited eye condition that causes sudden, painless vision loss, usually starting in one eye and then affecting the other within weeks to months. Most people notice blurred or dim central vision, trouble reading or recognizing faces, and colors looking washed out, while side (peripheral) vision is often spared. It typically appears in teens or young adults, more often in males, and is lifelong; vision loss can be severe, though a minority experience some spontaneous improvement. Doctors describe this as damage to the optic nerve driven by changes in mitochondrial DNA passed down through the maternal line; not everyone who carries the change will lose vision. Treatment focuses on protecting remaining vision and supporting daily life; the medication idebenone is approved in some regions, and low-vision tools, smoking avoidance, and genetic counseling are commonly recommended.
How many people live with Leber hereditary optic neuropathy?
As of 2023, applying a commonly cited prevalence for Leber hereditary optic neuropathy of about 1 in 30,000 to 1 in 50,000 suggests roughly 160,000 to 270,000 people worldwide are living with it. In the United States, using the 2023 population, this approach suggests about 7,000 to 11,000 people; these are estimates rather than direct counts and can vary by region and ancestry.
Overview
Leber hereditary optic neuropathySymptoms
Leber hereditary optic neuropathy causes painless, sudden or subacute central vision loss, starting in one eye and involving both within weeks to months. Early signs of Leber hereditary optic neuropathy include blurred central vision, difficulty reading, and faded colors.
Outlook and prognosis
Many living with Leber hereditary optic neuropathy (LHON) notice vision worsening over weeks to months, then stabilizing. Central vision loss is often permanent, but side vision usually remains, helping with mobility and daily tasks. Early support, low-vision tools, and genetic counseling can improve independence and planning.
Causes and risk factors
Leber hereditary optic neuropathy stems from mitochondrial DNA mutations, usually maternally inherited; occasionally new changes occur. Risk rises with male sex, young adult age, family history, smoking, heavy alcohol use, certain medications or toxins, and poor nutrition.
Genetic influences
Genetics are central in Leber hereditary optic neuropathy; most cases arise from mitochondrial DNA variants passed through the maternal line. Specific variants greatly affect risk and age of vision loss. Other factors—like smoking—can influence whether symptoms appear.
Diagnosis
Genetic diagnosis of Leber hereditary optic neuropathy pairs mitochondrial DNA testing with clinical clues—sudden, painless central vision loss and characteristic optic nerve changes—while imaging or labs may be used to rule out other causes.
Treatment and drugs
Treatment for Leber hereditary optic neuropathy focuses on protecting remaining vision, supporting daily activities, and, when appropriate, using therapies that target mitochondria. Options can include idebenone, avoidance of smoking and heavy alcohol, low‑vision aids, and genetic counseling. Some may be eligible for clinical trials or specialist-guided supplements.
Symptoms
Many people first notice a blurry or dim spot in the center of vision, making reading, using a phone, or recognizing faces harder. Leber hereditary optic neuropathy often starts in one eye and then involves the other over weeks to months, and the change is usually painless. Early features of Leber hereditary optic neuropathy often include central blurring and trouble telling colors apart. Features vary from person to person and can change over time.
A smudge or fog sits in the middle of what you’re looking at. Fine print and faces can look washed out or less sharp. This change is usually painless.
One eye is affected first, then the other days to months later. As both eyes are involved, reading, driving, and detailed tasks become much harder. This pattern is typical in Leber hereditary optic neuropathy.
Reds and greens can look faded or hard to tell apart. Clothes, traffic lights, or app icons may not look as vivid as before.
In medical terms, this is a central scotoma; in everyday life, it shows up as a dark or blurry patch right where you try to focus. Moving your eyes doesn’t make it go away.
How people usually first notice Leber hereditary optic neuropathy?
People often notice the first signs of Leber hereditary optic neuropathy as sudden, painless blurring or a gray “smudge” in the center of vision in one eye, with the other eye typically affected weeks to months later. This usually appears in late teens to early adulthood, more often in males, and colors may look washed out or dull as central vision fades while side vision stays relatively intact. Doctors recognize LHON by this pattern of rapid central vision loss, a family history suggestive of maternal inheritance, and eye exam features confirmed by genetic testing.
Types of Leber hereditary optic neuropathy
Leber hereditary optic neuropathy (LHON) has a few well-recognized genetic variants, each tied to a specific change in mitochondrial DNA. These variants can influence the chance of vision loss and, to a lesser extent, the age of onset and how severe symptoms become. People may notice different sets of symptoms depending on their situation. When talking about types of LHON, clinicians usually mean the specific mitochondrial gene changes rather than separate clinical stages.
m.11778G>A variant
This is the most common LHON variant worldwide and often carries a higher risk of severe, permanent central vision loss. Vision typically declines over weeks to months, usually starting in one eye then the other.
m.3460G>A variant
This type is linked to a moderate-to-high risk of vision loss and sometimes an earlier age at onset. Some may have a slightly better chance of partial visual recovery compared with the most common variant.
m.14484T>C variant
This variant is associated with a comparatively higher likelihood of visual improvement over time. Many living with this type of LHON still experience sudden central vision loss, but partial recovery is more common.
Rare mtDNA variants
Less common mitochondrial DNA changes can also cause LHON, but they are identified far less often. For many, the risk of vision loss and recovery is less predictable with these variants.
Can I slow down the onset of symptoms?
There’s no sure way to prevent or reliably delay the start of Leber hereditary optic neuropathy, but research suggests some choices may lower risk or push it later. The strongest evidence points to not smoking (and avoiding secondhand smoke) and avoiding heavy alcohol. There isn’t a proven medicine to prevent it yet, though studies are ongoing, so staying smoke-free and mindful about alcohol is a practical, positive step even though it can’t guarantee prevention.
What genetics can tell you about symptoms
Some people with LHON who carry the m.11778G>A change in the MT-ND4 gene lose central vision faster and more severely, often in both eyes. Variants m.3460G>A (MT-ND1) and m.14484T>C (MT-ND6) can bring milder loss and sometimes partial recovery.
Causes and risk factors
Leber hereditary optic neuropathy usually stems from a change in mitochondrial DNA, most often inherited from the mother, that makes the optic nerve more vulnerable to energy stress. Having a gene change doesn’t mean you’ll definitely develop the condition, and risk is higher in males and typically peaks in the teens to 30s; it’s also shaped by how many of your mitochondria carry the change and by your family’s mitochondrial background. Smoking, heavy alcohol use, and exposure to certain toxins or medicines that strain mitochondria can raise the chance that someone with the genetic change develops vision loss. Genetic counseling and testing can help clarify personal risk and guide steps such as avoiding smoking, maintaining good nutrition, and reviewing medications if you’re concerned about risk factors for Leber hereditary optic neuropathy.
What are the most common causes or risk factors?
Leber hereditary optic neuropathy (LHON) is most often caused by a change in mitochondrial DNA—the energy‑making parts of cells—that is passed down from the mother, so having maternal relatives with LHON is the main risk. Among people who carry this change, vision loss is more likely in men and in those who smoke; heavy alcohol use and exposure to certain toxins or medicines that can stress these energy‑making parts or harm the optic nerve can also raise the risk. While onset can vary, it most often begins in the late teens to early 30s.
Environmental and biological risk factors
Below are environmental and biological factors that can raise the chance that Leber hereditary optic neuropathy (LHON) shows up. Some risks are carried inside the body, others come from the world around us. Knowing these can help you act quickly if early symptoms of Leber hereditary optic neuropathy—like painless, sudden blurred central vision—appear.
The chance of vision loss is higher in males. Hormone effects and other biology may influence how vulnerable the optic nerve is in LHON. Females can be affected, but less often.
Onset of vision loss from LHON most often occurs in late teens to around the 30s. Risk outside this window is possible but lower.
System-wide illness and high fevers can strain the optic nerve’s energy supply. This stress can act as a trigger for sudden visual changes.
Some antibiotics, tuberculosis drugs, and antivirals can affect mitochondria and raise optic nerve vulnerability. When these are essential, doctors may monitor vision more closely in people already at risk.
Genetic risk factors
Leber hereditary optic neuropathy (LHON) happens when certain changes in mitochondrial DNA disrupt the cells that power the optic nerve. This section focuses on the genetic causes of Leber hereditary optic neuropathy, including how these changes are passed down in families. Carrying a genetic change doesn’t guarantee the condition will appear. Which variant you carry, your mitochondrial background, and sex-linked susceptibility all influence the chance of vision loss.
Primary mtDNA variants: Most cases come from one of three mitochondrial DNA changes—often called 11778, 14484, or 3460. These changes impair energy production in the optic nerve and drive Leber hereditary optic neuropathy. Genetic testing can identify these specific variants.
Maternal inheritance: Mitochondrial DNA is passed from mothers to all children, so risk travels through the maternal line. Fathers do not pass these variants to children.
Incomplete penetrance: Many people who carry the variant never lose vision. Risk is higher in males than females, and it can differ across families.
Heteroplasmy level: Some people carry a mix of mutated and typical mitochondrial DNA, which can change individual risk. In many families, the change is present in nearly all copies, but exceptions occur. Levels can also vary between tissues and among siblings.
Mitochondrial haplogroup: The broader mitochondrial background (for example, European haplogroup J) can modify how strongly a variant acts. This helps explain why risk can vary between populations and families.
Nuclear modifiers: Variants in nuclear genes that support mitochondrial function may raise or lower penetrance. Research continues to clarify which modifiers matter for Leber hereditary optic neuropathy.
De novo variants: Occasionally, a Leber hereditary optic neuropathy change appears for the first time in a family, so there may be no prior history. Future transmission then follows maternal inheritance rules.
Mitochondrial bottleneck: During egg development, the proportion of mutated mitochondrial DNA a mother passes can shift markedly. This can lead to big differences in risk between siblings.
Lifestyle risk factors
Leber hereditary optic neuropathy (LHON) is a genetic condition; lifestyle habits don’t cause it, but some can raise the chance that vision problems start or speed up. Risk is more of a probability than a promise. For people who carry LHON variants or notice early symptoms of LHON, steering clear of known triggers may help protect remaining vision. Understanding lifestyle risk factors for Leber hereditary optic neuropathy can help you choose safer routines.
Cigarette smoke can stress mitochondria and has been linked to a higher chance of LHON vision loss in carriers. Quitting smoking may reduce the risk of triggering optic nerve damage.
Frequent or heavy drinking can add oxidative stress that strains already vulnerable optic nerve cells in LHON. Cutting back or avoiding alcohol may lower the chance of worsening vision.
Diets low in key nutrients—especially B vitamins and overall protein—can make optic nerves more vulnerable. A balanced, regular eating pattern supports nerve metabolism in people with LHON.
Rapid weight loss or very low-calorie plans can deprive nerves of fuel and increase metabolic stress. In LHON, severe restriction may raise the risk of symptom onset or progression.
Risk prevention
Leber hereditary optic neuropathy (LHON) is genetic, so there’s no way to fully prevent the condition itself, but you can lower the chance that vision loss will be triggered. Prevention is about lowering risk, not eliminating it completely. For many, this means avoiding known triggers, staying on top of eye care, and planning ahead with genetic counseling if LHON runs in the family. Carriers and relatives may benefit from tailored guidance because risks can vary by age, sex, and lifestyle.
Avoid smoking and secondhand smoke, which are strong triggers for vision loss in LHON carriers. Tobacco smoke contains chemicals that can stress the optic nerve.
Heavy or frequent drinking may raise the chance of vision loss in LHON. If you drink alcohol, keep it light and avoid binges.
Before starting new medicines, ask whether any could stress the optic nerve or mitochondria. Talk to your doctor about which preventive steps are right for you.
If you carry an LHON variant or have affected relatives, schedule routine eye checks with an eye specialist. Seek urgent care for early symptoms of Leber hereditary optic neuropathy such as painless central blur, color changes, or dimmer vision.
Can you prevent Leber hereditary optic neuropathy?
There’s no sure way to prevent Leber hereditary optic neuropathy (LHON) because it comes from a genetic change passed down on the mother’s side. For people who carry this change, the most proven steps to lower risk are not smoking and avoiding heavy alcohol use. Genetic counseling can help families understand their chances and discuss reproductive options, but none of these steps can guarantee prevention.
Transmission
Leber hereditary optic neuropathy (LHON) is not contagious and cannot be caught from someone else. It results from changes in mitochondrial DNA and is passed down the maternal line, which is how Leber hereditary optic neuropathy is inherited. Both sons and daughters can inherit the mutation, but only mothers with the mutation can pass it to their children; fathers do not transmit it. Each child of a mother who carries the LHON mutation is at risk of inheriting it, although not everyone who inherits the change will develop symptoms, and males are affected more often than females. Rarely, LHON can appear for the first time in a family due to a new mutation.
When to test your genes
Consider genetic testing if you have painless, sudden central vision loss; a maternal family history of similar vision loss; or you’re a young adult male at higher risk. Testing also helps if you smoke, drink heavily, or take mitochondria‑stressful drugs, since results can guide prevention and monitoring. If positive, relatives on your mother’s side may benefit from testing, too.
Diagnosis
For many, the first signs are day-to-day—letters seem to fade on the page, colors look washed out, and driving or recognizing faces becomes harder in one eye, then often the other weeks later. To make the diagnosis of Leber hereditary optic neuropathy, eye specialists look for a typical pattern of vision loss and optic nerve changes, then confirm it with targeted genetic tests. Genetic testing may be offered to clarify risk or guide treatment.
Doctors usually begin with a detailed symptom timeline and eye examination focused on central vision and color changes. They look for painless, subacute vision loss that often starts in one eye and then involves the other.
The back of the eye is checked for characteristic optic nerve findings like swelling without true inflammation and fine blood vessel changes. These patterns help separate LHON from optic neuritis and other causes.
OCT maps the optic nerve layers to show early swelling and later thinning of nerve fibers. These structural changes support the clinical picture and help track progression over time.
Simple color plates and visual field testing look for red–green color loss and central or cecocentral blind spots. These functional tests match the way LHON affects reading, face recognition, and distance vision.
How is Leber hereditary optic neuropathy diagnosed?
Doctors diagnose Leber hereditary optic neuropathy (LHON) by the typical pattern of sudden, painless central vision loss and a careful eye exam with vision and color checks, tests that map central and side vision, and a close look at the nerve at the back of the eye, sometimes using scans that measure its thickness. They also run tests to rule out other causes of damage to this nerve, such as blood tests, MRI, and sometimes electrical tests that check how well signals travel from the eye to the brain. A genetic blood test can confirm LHON by finding a gene change that is usually passed down through the mother, but doctors rely mainly on the clinical picture and excluding other causes.
Stages of Leber hereditary optic neuropathy
Leber hereditary optic neuropathy often unfolds in phases that eye specialists recognize. Early symptoms of Leber hereditary optic neuropathy can include painless blurring of central vision and trouble with color, typically in one eye first. Different tests may be suggested to help confirm the diagnosis and track changes. Genetic testing and regular eye exams guide timing of treatment and low-vision support.
Carrier stage
No vision symptoms are present. A mitochondrial genetic change is there, but eyesight is normal. Avoiding smoking and limiting alcohol may lower the chance of vision loss.
Prodromal phase
Subtle color trouble or mild central blur may come and go. Eye tests can show early optic nerve stress even when day-to-day vision seems normal. This phase can be brief or easy to miss.
Acute phase
In Leber hereditary optic neuropathy, sudden, painless central blur often starts in one eye, with the second eye affected within weeks. Colors look washed out and reading or recognizing faces becomes hard. Vision can drop quickly over days to weeks.
Subacute phase
Over the next 1–6 months, vision in one or both eyes often worsens and then starts to level off. Some people notice blind spots growing toward the center. Doctors track this with color vision and visual field tests.
Chronic phase
After about 6–12 months, vision usually reaches a new baseline and stays relatively stable. Partial recovery can occur, more often in younger people and some genetic subtypes. Low-vision tools and rehab can support daily activities.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Leber hereditary optic neuropathy (LHON), vision loss comes on over weeks to months, often in one eye first and then the other. Central vision is usually most affected, which can make reading, driving, or recognizing faces hard. Early symptoms of Leber hereditary optic neuropathy may include blurry or dim central vision and trouble with color contrast, while side vision often stays better. Even though it can feel overwhelming, some people experience partial recovery, especially if vision changes start at a younger age or if treatment begins early.
Doctors call this the prognosis—a medical word for likely outcomes. About half of affected men and a smaller share of women develop significant central vision loss, typically in young adulthood, though LHON can appear at other ages. A minority regain meaningful detail vision over time, but many live with stable low vision long term. LHON itself usually does not shorten life expectancy, but certain gene changes can be linked to heart rhythm problems, so screening for cardiac risks is wise.
With ongoing care, many people maintain independence by using low-vision tools, orientation and mobility training, and workplace or school accommodations. Avoiding smoking and heavy alcohol use is recommended, since these can stress the energy-making parts of cells that are already vulnerable in LHON. Genetic testing can sometimes provide more insight into prognosis, including the specific mitochondrial variant and the chance of recovery. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Living with Leber hereditary optic neuropathy often means lasting changes in central vision that affect reading, faces, and screens. Long-term effects vary widely, and some stabilize after the first months of vision loss. Many experience severe central blur in both eyes, with color fading, while side vision is usually spared. A smaller group may see partial improvement over years, influenced by the specific gene variant and other factors.
Persistent central blur typically limits reading small print and recognizing faces. Side (peripheral) vision often remains, but detail in the center stays reduced over the long term.
Most people with Leber hereditary optic neuropathy develop vision loss in both eyes, sometimes weeks to months apart. After the rapid phase, vision often plateaus at a stable level.
Reds and greens may look washed out or dull. This reduced color contrast can persist even if overall clarity partially improves.
A dense central scotoma can form, creating a gap in detail right where you want to focus. Over time, this blind spot can make tasks like reading, threading a needle, or using a phone screen difficult.
How is it to live with Leber hereditary optic neuropathy?
Living with Leber hereditary optic neuropathy often means a sudden, painless blur in one eye that progresses to the other over weeks to months, leaving central vision washed out while side vision stays relatively intact. Daily life shifts toward strategies that lean on peripheral sight—larger, high-contrast displays, magnification, orientation and mobility training, and voice-based tech—to keep reading, navigating, school, and work feasible. Many find the emotional whiplash of rapid vision change the hardest part, and partners, family, and friends may need guidance on how to support without overstepping—offering rides, reading help, or patience while new routines settle in. With low-vision services, workplace or school accommodations, and peer support, people can regain independence and confidence even as the condition stabilizes.
Treatment and drugs
Treatment for Leber hereditary optic neuropathy (LHON) focuses on protecting remaining vision, supporting daily life, and, when possible, slowing damage to the optic nerve. Medicines that aim to protect nerve cells include idebenone (approved in some countries) and related antioxidant or “mitochondrial support” therapies; they tend to work best when started early, and a doctor may adjust your dose to balance benefits and side effects. For vision that has already declined, low-vision rehabilitation, magnifiers, screen readers, high-contrast lighting, and mobility training can help you stay independent at home, work, and school. In select situations, specialists may discuss clinical trials or, rarely, targeted treatments for specific gene changes; your doctor can help weigh the pros and cons of each option. Alongside medical treatment, lifestyle choices play a role, including not smoking and limiting heavy alcohol use, because these can stress mitochondria and may worsen LHON.
Can you cure Leber hereditary optic neuropathy?
There’s no cure for Leber hereditary optic neuropathy (LHON) at this time. Treatment focuses on protecting remaining sight and may lead to some improvement for some people—this can include stopping smoking and heavy alcohol use, using low-vision tools and rehab, and in some countries a medicine called idebenone. Research on gene-based treatments is ongoing, but these are not standard care yet.
Non-drug treatment
Non-drug care for Leber hereditary optic neuropathy focuses on protecting independence, safety, and quality of life while vision is reduced. Beyond prescriptions, supportive therapies can make day‑to‑day tasks easier and help you stay active at home, school, and work. Recognizing early symptoms of Leber hereditary optic neuropathy can lead to faster referral for low‑vision services and training. Plans are tailored to age, job or schooling, and how quickly vision changed, and they often evolve over time.
Structured programs, like low-vision rehabilitation, can help you use remaining sight more effectively. Training may include eccentric viewing, contrast strategies, and device selection. Care is typically delivered by optometrists and therapists working as a team.
Handheld magnifiers, screen readers, and text-to-speech tools can make reading and navigation manageable. Built‑in phone and computer accessibility settings often cover most daily needs. A specialist can match devices to your goals and budget.
Orientation and mobility training teaches safe navigation at home and outdoors. Skills may include white cane use, route planning, and street‑crossing techniques. This improves confidence and reduces fall risk.
An occupational therapist helps adapt cooking, self‑care, and work tasks to your vision level. Small changes to routines and layout can save time and prevent injury. They can also advise on workplace accommodations.
Your genes may have an impact on how drugs work for you
Some people with Leber hereditary optic neuropathy respond differently to treatments because gene variants shape how their mitochondria handle stress and therapies. Genetic testing can guide choices, dosing, and expectations, helping tailor options like idebenone or clinical trial enrollment.
Pharmacological treatments
Drug treatment for Leber hereditary optic neuropathy is limited, and options mainly aim to protect the optic nerve’s energy supply. Idebenone is the best-studied and is authorized in parts of Europe, while in the US it may be used off-label. Other antioxidants are sometimes tried, though evidence is mixed, and several agents remain investigational. Not everyone responds to the same medication in the same way.
This synthetic antioxidant helps mitochondria make energy and may protect nerve fibers in the optic nerve. Starting during early symptoms of Leber hereditary optic neuropathy or within the first year of vision loss seems most helpful in studies. It is authorized in several EU countries; in the US, doctors may prescribe it off-label.
This over-the-counter antioxidant (also sold as ubiquinone or ubiquinol) supports the same energy pathway as idebenone. Evidence for vision improvement is mixed, so it’s sometimes used when idebenone isn’t available or as an add-on. It’s generally well tolerated but may not change the course of LHON for many.
An investigational antioxidant designed to rebalance cell redox systems is being studied for LHON. Access is typically limited to clinical trials or expanded-access programs, and it does not have regulatory approval for LHON. Early research is ongoing, so proven benefit and dosing are not yet established.
This antioxidant supplement is sometimes tried alongside other care to support mitochondrial function. Clinical evidence in LHON is limited, so it should not replace idebenone where that is recommended. Discuss use with your clinician to avoid duplicating therapies or interactions.
Genetic influences
In Leber hereditary optic neuropathy, the genetic change usually sits in mitochondrial DNA—the small set of genes inside the cell’s energy centers—rather than in the chromosomes. Because mitochondrial DNA is passed down by mothers, a woman with the gene change can pass it to any of her children, while fathers do not pass it on. Having a genetic risk is not the same as having the disease itself. Many people who carry an LHON-related change never develop vision loss, and men are affected more often than women; smoking, heavy alcohol use, and some environmental exposures may increase the chance that symptoms appear. Different families may have different mitochondrial variants, which can influence when symptoms start, including early symptoms of Leber hereditary optic neuropathy, and how severe the vision loss becomes. Genetic testing can confirm the specific mitochondrial change and help relatives understand their own risk, often alongside genetic counseling to plan monitoring and discuss family implications.
Is Leber hereditary optic neuropathy genetic?
Genetics are central in Leber hereditary optic neuropathy; most cases arise from mitochondrial DNA variants passed through the maternal line. Specific variants greatly affect risk and age of vision loss. Other factors—like smoking—can influence whether symptoms appear.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and occur frequently across the population. Most variants do not directly affect health and simply reflect natural human variation. With many genes, having a variant tied to a condition signals a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. Still, in some situations, a single well-characterized variant in a particular gene can, on its own, be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Leber hereditary optic neuropathy, the specific mitochondrial DNA change can shape both treatment options and how likely a therapy is to help. Alongside medical history and an eye exam, genetic testing can confirm the exact LHON variant and guide choices about medicines and clinical trials. For example, people with the ND4 variant may be considered for research gene‑therapy approaches that target that gene, while other variants are not eligible, so pinpointing the mutation matters. Idebenone is used in some regions for Leber hereditary optic neuropathy; starting it soon after vision changes and avoiding smoking seem to matter most, and both the mutation type and how many of your mitochondria carry it may influence response. Because LHON involves mitochondrial function, certain drugs that strain mitochondria (such as some antibiotics or antivirals) may be used with extra caution, and your care team will review your medication list to reduce avoidable risk. Classic drug–gene dosing rules are less central here, but genetics still steers care by clarifying prognosis, shaping eligibility for research treatments, and alerting doctors to medicines that could worsen Leber hereditary optic neuropathy.
Interactions with other conditions
Leber hereditary optic neuropathy can interact with other conditions, most notably diseases that affect the brain and spinal cord. Doctors call it a “comorbidity” when two conditions occur together. In some people—especially women—features similar to multiple sclerosis may develop around the time vision changes begin, which can intensify vision loss and add symptoms like numbness, weakness, or balance problems. Certain medicines that tax the cell’s energy systems, including some tuberculosis treatments and specific antibiotics, may worsen optic nerve damage in those with LHON, so medication lists deserve careful review. When eye diseases such as glaucoma or a history of optic neuritis are also present, early symptoms of Leber hereditary optic neuropathy can be harder to recognize and may be attributed to the other problem. A subset of people experience a broader “LHON plus” picture with nerve, movement, or heart rhythm issues, making shared care between eye specialists, neurologists, and sometimes cardiologists important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Leber hereditary optic neuropathy?
Similar symptoms—especially sudden, painless loss of sharp central vision—can also happen with optic nerve inflammation (optic neuritis, often linked to multiple sclerosis), damage from toxins or poor nutrition (long-term alcohol or tobacco use, certain medicines, or low vitamin B12), or poor blood flow to the optic nerve in older adults. Pressure on the nerve from a growth behind the eye and another inherited optic nerve condition called dominant optic atrophy can look very similar. Diseases that affect the center of the retina, such as age-related macular degeneration, may also blur central vision at first, although the eye exam looks different.
History
Throughout history, people have described sudden, painless vision loss in young adults, often affecting one eye and then the other within weeks. Families told stories of brothers or cousins who lost central vision in their late teens or twenties, while others in the same family saw normally for life. These patterns puzzled doctors for generations because routine eye exams could look nearly normal at first, even as reading and recognizing faces became hard.
First described in the medical literature as a family-linked optic nerve disorder in the 19th century, Leber hereditary optic neuropathy drew attention because it clustered in maternal lines. In many families, men were more often affected, while women could carry the risk without losing vision themselves. From these first observations, clinicians kept careful pedigrees and noticed that standard inheritance rules did not fully explain who developed symptoms.
As medical science evolved, researchers recognized that the optic nerve—the cable carrying signals from the eye to the brain—was the main site of injury. Early reports focused on the striking loss of sharp, central vision and the characteristic changes seen around the optic disc. Still, many questions remained about why some relatives were affected and others were not, even within the same household and diet.
Advances in genetics in the late 20th century provided the turning point. Scientists discovered that Leber hereditary optic neuropathy is linked to specific changes in mitochondrial DNA, which is passed down from mothers to all their children. This explained the maternal inheritance pattern and why men and women face different levels of risk. It also clarified why early symptoms of Leber hereditary optic neuropathy could appear in otherwise healthy people and why age at onset varies.
In recent decades, knowledge has built on a long tradition of observation. Studies mapped several mitochondrial variants that raise risk, and long-term follow-up showed that some people experience partial visual recovery, while many have lasting central vision loss. These historical steps organized the condition into a clear diagnosis that unites family stories, eye exam findings, and genetic testing.
Despite evolving definitions, the core story has stayed the same: typically a sudden drop in central vision in one eye, followed by the other, usually in young adulthood. What has changed is our ability to confirm the cause, counsel families about inheritance, and discuss options for support and, in some cases, treatment. Knowing the condition’s history helps explain why careful family history and modern genetic testing now sit side by side in guiding care for people living with Leber hereditary optic neuropathy.